COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 240: Articles 2391-2400  | Next

Identification of potential SARS-CoV-2 genetic markers resulting from host domestication.
Wisniewski, J., CHEN, H.-C.
10.1101/2024.07.27.605454 — Posted: 2024-07-29
Assessing Healthy Vaccinee Bias in COVID-19 Vaccine Effectiveness Studies: A National Cohort Study in Qatar
Chemaitelly, H., Ayoub, H. H., Coyle, P., Tang, P., Hasan, M. R., YASSINE, H. M., Althani, A. A., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G., Al-Kuwari, M. G., Al-Romaihi, H. E., Al-Thani, M. H. J., Al-Khal, A., Bertollini, R., Butt, A. A., Abu-Raddad, L. J.
10.1101/2024.07.28.24311115 — Posted: 2024-07-29
Revamping the Day Hospital Program at North York General Hospital in response to COVID-related changes in patient demographics
Zhou, C., Doval, I., Liu, R.
10.1101/2024.07.27.24310746 — Posted: 2024-07-29
Characterisation of Microbial Community Dynamics and Antibiotic Resistance Gene Dissemination in Malaysian Wastewater during the COVID-19 Pandemic
Shahid, U., Hooi, S. L., Lim, S. Y., Mohd Aris, A., Khor, B. C., Ayub, Q., Tan, H. S.
10.1101/2024.07.25.24311021 — Posted: 2024-07-27
Using the Emergency Care Data Set for the epidemiological surveillance of Children and Young People aged less than 18 years: a case study of COVID-19 in England 2020-2023
Boateng, J., Oeser, C., Seghezzo, G., Harman, K., Dabrera, G., Webster, H., Hope, R., Thelwall, S., Lamagni, T.
10.1101/2024.07.26.24310711 — Posted: 2024-07-27
Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans
Kent, S., Li, S., Amarasena, T. H., Reynaldi, A., Lee, W. S., Leeming, M. G., O'Connor, D., Nguyen, J., Kent, H. E., Caruso, F., Juno, J. A., Wheatley, A. K., Davenport, M. P., Ju, Y.
10.1101/2024.07.25.24311039 — Posted: 2024-07-27
Optimal annual COVID-19 vaccine boosting dates following previous booster vaccination or breakthrough infection
Townsend, J. P., Hassler, H. B., Dornburg, A.
10.1101/2024.07.25.24311016 — Posted: 2024-07-26
Development and Validation of Novel Cell-free Direct Neutralization Assay for SARS-CoV-2
Lim, J. Y., Fiore, A., Le, B., Minzer, C., White, H., Burinski, K., Janwari, H., Wright, D., Perebikovsky, S., Davis, R., Okrongly, D., Srinivasan, A.
10.1101/2024.07.24.24310905 — Posted: 2024-07-26
Long-term neurological and gastrointestinal sequelae of SARS-CoV-2, influenza, and other neurotropic infections with and without vaccination
Konings, B., Villatoro, L., Burns, R., Barahona, G., McKnight, M., Hui, K., Tack, J., Pasricha, P. J.
10.1101/2024.07.25.24310990 — Posted: 2024-07-26
Evaluation of SARS-CoV-2 antibody response between paired fingerprick (hemaPEN) and venepuncture collected samples in children and adults
mazarakis, N., Toh, Z. Q., Nguyen, J., Higgins, R., Rudge, J., Whittle, B., Woudberg, N. J., Devine, J., Gooley, A., Lapierre, F., Crawford, N. W., Tosif, S., Licciardi, P.
10.1101/2024.07.24.24310954 — Posted: 2024-07-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).